Calls to doctor's office may delay stroke treatment

In two separate studies, one in the United States and the other in Australia, investigators found possible significant delays when doctors’ offices were called first. Calling an emergency number or an ambulance is the quickest way to reach a hospital within the three-hour window of opportunity for acute stroke treatment that can potentially avert serious post-stroke disability.

In the West Virginia study (P523), researchers randomly called primary care physicians’ offices seeking advice for hypothetical stroke or heart attack symptoms. About 40 receptionists were asked to choose one of four responses to the scenario: wait to see if symptoms go away, schedule an office appointment later that day, schedule an appointment within two days, or call 9-1-1.

The receptionists were aware of heart attack symptoms and correctly advised an emergency 9-1-1 call for heart attack scenarios. However, for stroke scenarios, nearly one-third of the receptionists recommended scheduling an appointment later in the day if symptoms continued.

“Calling 9-1-1 is the only correct answer,” said co-author Stephen Davis, M.P.A., M.S.W., author of the study and an adjunct assistant professor of emergency medicine at West Virginia University–Morgantown. “We seem to have done an excellent job educating people about heart attacks, but we need more work with stroke education. Almost 30 percent of the receptionists recommended a wait-and-see strategy. We can do much better than that.”

The study was presented by lead author Brett Jarrell, M.D., an assistant professor of emergency medicine at the University of Kentucky.

The second study (P537) was not a hypothetical survey. It included interviews with 198 patients who had arrived at three Australian emergency rooms via ambulance over six months. Researchers found that calling doctors’ offices lengthened the time before an ambulance was called and delayed the patient reaching hospital.

Overall, 22 percent of emergency room stroke patients had first called a family doctor. Only 32 percent called an ambulance immediately.

Among those who called a family doctor, 45 percent were screened over the phone and advised to call an ambulance. Thirty-six percent were advised to be seen by the doctor. Of these two groups, those advised to call an ambulance experienced a median time of 92 minutes to ambulance call while those who waited to be examined experienced median times of 412 minutes – nearly 7 hours prior to an ambulance being called.

The delay in calling an ambulance was nearly 10 times greater for those who waited to be seen by their physician (median 412 minutes) than for those who called an ambulance immediately (median 44 minutes).

Time to hospital arrival was more than five times greater for patients who saw their physician first (median 475 minutes) compared to those who first called an ambulance (median 92 minutes), said study author Ian T. Mosley M.B.A., R.N.

“Family doctors and their staff have an important role to play in reducing potential delays by screening calls and providing advice for stroke patients who call their family doctor following the onset of stroke symptoms,” said Mosley, who is a research fellow at the National Stroke Research Institute at the University of Melbourne. “The best response for people who experience or observe stroke symptoms in others is to call an ambulance.”

The study was presented by senior author Helen M. Dewey, M.B.B.S., Ph.D., Associate Director of the National Stroke Research Institute and Associate Professor in the Department of Medicine at the University of Melbourne.

The American Stroke Association recommends calling 9-1-1 immediately if any of these stroke warning signs occur:

-- Sudden numbness or weakness of the face, arm or leg, especially on one side of the body
-- Sudden confusion, trouble speaking or understanding
-- Sudden trouble seeing in one or both eyes
-- Sudden trouble walking, dizziness, loss of balance or coordination
-- Sudden, severe headache with no known cause.

Source: American Heart Association

Brain inflammation may be friend, not foe, for Alzheimer's patients
Inflammation in the brain may not be so bad after all when it comes to Alzheimer’s disease.In the June 1 issue of the Journal of Clinical Investigation, a team of scientists from the University of Rochester Medical Center shows that a key inflammatory regulator, a known villain when it comes to parsing out damage after a stroke and other brain injuries, seems to do the opposite in Alzheimer’s disease, protecting the brain and helping get rid of clumps of material known as plaques that are a hallmark of the disease.
New study ties ending moderate drinking to depression
Scientific evidence has long suggested that moderate drinking offers some protection against heart disease, certain types of stroke and some forms of cancer.
Statins have unexpected effect on pool of powerful brain cells
Cholesterol-lowering drugs known as statins have a profound effect on an elite group of cells important to brain health as we age, scientists at the University of Rochester Medical Center have found. The new findings shed light on a long-debated potential role for statins in the area of dementia.
Reprogramming Adult Stem Cells in the Brain
In recent years, stem cell researchers have become very adept at manipulating the fate of adult stem cells cultured in the lab. Now, researchers at the Salk Institute for Biological Studies achieved the same feat with adult neural stem cells still in place in the brain. They successfully coaxed mouse brain stem cells bound to join the neuronal network to differentiate into support cells instead.
Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. The research, an important step toward developing new treatments for stroke, Alzheimer's, Parkinson's and other neurological conditions showed that mice afflicted by stroke showed tangible therapeutic improvement following transplantation of these cells. None of the mice formed tumors, which had been a major setback in prior attempts at stem cell transplantation.
Stroke study reveals key target for improving treatment and suggests that Gleevec may help
Research in mice shows why tPA carries risks as well as benefits, and suggests that Gleevec or other drugs could prevent problems
For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.
Drug reverses mental retardation caused by genetic disorder
UCLA mouse study offers hope for correcting how autism disrupts brain
UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Because half of TSC patients also suffer from autism, the findings offer new hope for addressing learning disorders due to autism. Nature Medicine publishes the findings in its online June 22 edition.
Ice cores map dynamics of sudden climate changes
New, extremely detailed data from investigations of ice cores from Greenland show that the climate shifted very suddenly and changed fundamentally during quite few years when the ice age ended. Researchers from the Niels Bohr Institute of University of Copenhagen have together with an international team analysed the ice cores from the NorthGRIP drilling through the Greenland ice cap, and the epoch-making new results have been published in the highly esteemed scientific journal Science and in Science Express.

Calls to doctor's office may delay stroke treatment

Related stories:

News discussion: